CliffBio
small molecule

LEVALBUTEROL HYDROCHLORIDE

LEVALBUTEROL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVALBUTEROL HYDROCHLORIDE
Active ingredientLEVALBUTEROL HYDROCHLORIDE
StrengthEQ 0.042% BASE
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalDecember 2013
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEVALBUTEROL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio